All Type of News
LG to develop a new modified osteoarthritis drug.LG Life Science has succeeded in developing Hyruan plus, a degenerative osteoarthritis drug having 6 months to one year sustained relieving effects only by 3 times administratio...
|
20 folds more increase of prostate cancer over 20 years.
The prostate cancer diagnosis was 20.6 times more increased during the past 20 years and the mortality also rose to 15.6 times, showing a serious fatality to the 50s of Koreans.
The Korea Society of Urology (KSU) (...
Zuellig blamed for massive drug logistic troubles.
On the 4th day of the Zuellig's labor strike a serious logistic problem was erupted from 11:00 a.m. on Sept. 1 whereas Sept. 2 will be the day for most of Zuellig's customers to get massive supplies.
A dignitary of...
Zuellig labor union about to strike on Aug. 29
The labor union of Zuellig took a strike on Aug. 29 after determining the group strike by a 85% vote majority in favor of the strike on Aug. 18. The Union expected any compromise up to Aug. 29 but failed to narrow the...
NHI coverage to extend for anti-cancer drugs from Sept.
Effective from Sept. 1, the NHI coverage will be extended to the anti-cancer drugs, anti-vomiting drugs and narcotic pain killers for cancer pains, including anastrozole (Amylidex tab.), capecitabine (Zeloda tab.) and...
Pharmacies got damaged by maker's poor managed salesmen.
Quite a number of poorly managed salesmen of the drug industries have made serious rifts and disputes with retail pharmacies largely due to their style of poor pharmacy business relationships.
Before the medical a...
AZ Korea successfully closed campaign for cancer families.
AstraZeneca Korea successfully completed a special marketing promotional campaign called "Drawing a picture of Hope" at Ga il fine art museum located at Ga Pyeong, Gyeonggi province on Aug. 28 in attendance of about 3...
Unprecedented success of Amodipin in prescription drug markets.Hanmi has achieved to generate about 3 million prescriptions of Amodipin (amlodipine). an anti-hypertension drug, only in a year after its market entry, which is unprecedented i...
|
KFDA chief commissioner to visit U. S. FDA.
Chief Commissioner Kim Jeong-sook of KFDA visited the U. S. FDA and JIFSAN (Joint Institute for Food Safety and Applied Nutrition) from Aug. 28 to Sept. 1.
In her FDA visit she will discuss diverse cooperative plan...
Ewha to transfer Anapa technology to Fresenius kabi AG.
Ewha pharmaceutical company agreed with Fresenius kabi AG, a german drug company to sell 25% of its equity under the conditions that Fresenius kabi AG would purchase additional stakes until 2009 and such investment sh...
